Leona

-83%

est. 2Y upside i

HealthcareAI & MLSeed

Leona is on a mission to empower everyone to take the best care of themselves, their patients, and their loved ones. They leverage the latest in AI to empower doctors to securely and intelligently manage patient care through WhatsApp, saving them hours every day so they can grow their practice.

Rank

#240

Sector

Healthtech, AI, SaaS

Est. Liquidity

~4Y

Data Quality

Data: Medium

Leona Health presents a strong upside opportunity due to its innovative AI co-pilot addressing a critical need in Latin American healthcare, backed by top-tier investors.

Last updated: February 23, 2026

Bull (35%)+400%

Leona achieves rapid market penetration and expands product offerings, becoming the dominant AI co-pilot for doctors in Latin America and beyond, leading to a successful Series B/C at a significantly higher valuation.

Base (25%)+100%

Leona continues to grow steadily, securing further funding rounds and expanding its user base, but faces some competitive pressure and slower international expansion than hoped.

Bear (40%)-70%

Leona struggles with regulatory hurdles, intense competition, or Meta introduces competing features, severely impacting its growth and market share, leading to a down round or limited exit.

Est. time to liquidity~4.0 years

Preference Stack Risk

moderate

With $14M in total funding and an estimated $90M post-money valuation, investors hold $14M in liquidation preferences. In an exit at or below $14M, common stock would receive nothing. At an exit of $90M, investors would take 15.55% ($14M) before common shareholders.

Dilution Risk

high

As a Seed stage company, Leona Health will likely require several more funding rounds (Series A, B, C, etc.) to reach an exit, which will lead to significant dilution for early employees.

Secondary Liquidity

none

At this early stage, there is typically no active secondary market for shares, and tender offers are highly unlikely.